niacin extended release
Selected indexed studies
- Niacin extended-release/simvastatin. (Drugs, 2008) [PMID:18973399]
- Extended-release niacin (nicotinic acid)/laropiprant. (Drugs, 2009) [PMID:19678716]
- Extended-release niacin for modifying the lipoprotein profile. (Expert Opin Pharmacother, 2004) [PMID:15163282]
_Worker-drafted node — pending editorial review._
Connections
niacin extended release is a side effect of
Sources
- Niacin extended-release/simvastatin. (2008) pubmed
- Niacin extended release (ER)/simvastatin (Simcor®): a guide to its use in lipid regulation. (2010) pubmed
- Extended-release niacin (nicotinic acid)/laropiprant. (2009) pubmed
- Niacin extended-release/lovastatin: combination therapy for lipid disorders. (2002) pubmed
- Extended-release niacin for modifying the lipoprotein profile. (2004) pubmed
- Extended-release niacin with laropiprant : a review on efficacy, clinical effectiveness and safety. (2012) pubmed
- Effects of extended-release niacin with laropiprant in high-risk patients. (2014) pubmed
- Extended-release niacin/lovastatin: the first combination product for dyslipidemia. (2004) pubmed
- Lovastatin and extended-release niacin combination product: the first drug combination for the management of hyperlipidemia. (2002) pubmed
- Effect of extended-release niacin on plasma lipoprotein(a) levels: A systematic review and meta-analysis of randomized placebo-controlled trials. (2016) pubmed